当前位置:首页 - 行情中心 - 华森制药(002907) - 财务分析 - 现金流量表

华森制药

(002907)

  

流通市值:49.87亿  总市值:61.43亿
流通股本:3.39亿   总股本:4.18亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金422,963,930.22196,111,535.46813,988,252.62614,186,041.27
  收到的税费返还123,741.34123,741.341,438,103.711,438,103.71
  收到其他与经营活动有关的现金7,401,172.273,801,926.9724,521,350.8322,545,578.85
  经营活动现金流入小计430,488,843.83200,037,203.77839,947,707.16638,169,723.83
  购买商品、接受劳务支付的现金122,688,498.4650,129,944.99279,456,370.8218,495,293.33
  支付给职工以及为职工支付的现金88,874,667.5651,339,112.42161,655,482.07121,601,818.12
  支付的各项税费52,791,438.8422,713,914.78105,131,206.1480,968,255.41
  支付其他与经营活动有关的现金111,472,695.751,377,682.06231,464,825.68192,311,937.1
  经营活动现金流出小计375,827,300.56175,560,654.25777,707,884.69613,377,303.96
  经营活动产生的现金流量净额54,661,543.2724,476,549.5262,239,822.4724,792,419.87
二、投资活动产生的现金流量:
  收回投资收到的现金350,335,386200,000,000644,284,821.33550,000,000
  取得投资收益收到的现金3,528,788.052,053,938.735,788,519.75,349,047.49
  处置固定资产、无形资产和其他长期资产收回的现金净额--6,559,502.26,500,000
  收到的其他与投资活动有关的现金--5,308,473.5-
  投资活动现金流入小计353,864,174.05202,053,938.73661,941,316.73561,849,047.49
  购建固定资产、无形资产和其他长期资产支付的现金18,943,502.696,974,108.8714,557,492.368,892,142.46
  投资支付的现金347,471,700197,471,700840,000,000690,000,000
  取得子公司及其他营业单位支付的现金----447,333.24
  支付其他与投资活动有关的现金--12,000,000-
  投资活动现金流出小计366,415,202.69204,445,808.87866,557,492.36698,444,809.22
  投资活动产生的现金流量净额-12,551,028.64-2,391,870.14-204,616,175.63-136,595,761.73
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金16,703,852.56-35,495,685.2935,495,686.7
  支付其他与筹资活动有关的现金452,897.1240,848.554,247,304.756,105,250.17
  筹资活动现金流出小计17,156,749.66240,848.5539,742,990.0441,600,936.87
  筹资活动产生的现金流量净额-17,156,749.66-240,848.55-39,742,990.04-41,600,936.87
四、汇率变动对现金及现金等价物的影响-129,485.5-65,485.02-95,317.35-179,691.37
五、现金及现金等价物净增加额24,824,279.4721,778,345.81-182,214,660.55-153,583,970.1
  加:期初现金及现金等价物余额274,337,234.85274,337,234.85456,551,895.4456,551,895.4
  期末现金及现金等价物余额299,161,514.32296,115,580.66274,337,234.85302,967,925.3
补充资料:
  净利润55,953,671.01-55,210,478.38-
  资产减值准备583,194.64-1,944,374.59-
  固定资产和投资性房地产折旧32,639,213.53-66,643,587.07-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧32,639,213.53-66,643,587.07-
  无形资产摊销15,573,845.5-20,871,579.12-
  长期待摊费用摊销2,145,567.47-3,282,055.23-
  处置固定资产、无形资产和其他长期资产的损失---10,245,671.69-
  固定资产报废损失-1,459.98-442,810-
  公允价值变动损失-1,270,498.82--1,417,619.96-
  财务费用363,353.56--4,291,235.47-
  投资损失1,734,617.83--8,276,482.1-
  递延所得税-678,412.22--2,735,652.69-
  其中:递延所得税资产减少401,050.21--2,464,061.82-
    递延所得税负债增加-1,079,462.43--271,590.87-
  存货的减少18,232,247.8-1,411,880.96-
  经营性应收项目的减少-43,039,405.6--79,842,265.73-
  经营性应付项目的增加-27,972,224.15-18,667,461.39-
  现金的期末余额299,161,514.32-274,337,234.85-
  减:现金的期初余额274,337,234.85-456,551,895.4-
  现金及现金等价物的净增加额24,824,279.47--182,214,660.55-
公告日期2026-08-212026-04-302026-04-242025-10-29
审计意见(境内)标准无保留意见
TOP↑